EurekaMag.com logo
+ Translate

The prevalence of tardive dyskinesia in a population of long term schizophrenic patients


, : The prevalence of tardive dyskinesia in a population of long term schizophrenic patients. Nervenarzt 57(2): 116-118

A population of long-term hospitalized schizophrenic patients (no. = 76) were studied for symptoms of tardive dyskinesia with the aid of the Abnormal Involuntary Movements scale. The prevalence rate was 25%. The direct influence of the potential risk factors age, sex, duration of treatment with neuroleptics, duration of hospitalization, treatment with electroshock therapy and treatment with anticholinergic agents, on the appearance of tardive dyskinesia were checked by means of discriminant and covariance analysis techniques. A statistically significant direct effect could only be established for duration of treatment with neuroleptics.

(PDF 0-2 workdays service)

Accession: 006740526

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Rittmannsberger, H.; Schöny, W., 1986: Prevalence of tardive dyskinesia in long-term hospitalized schizophrenic patients. Der Nervenarzt 57(2): 116-118

Byne, W.; White, L.; Parella, M.; Adams, R.; Harvey, P.D.; Davis, K.L., 1998: Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment. Chronically hospitalized geriatric inpatients with schizophrenia are at particular risk for both tardive dyskinesia (TD) and cognitive impairment but have been insufficiently studied in this regard. Similarly, the relationship between TD and cogni...

Byne, W.; White, L.; Parella, M.; Adams, R.; Harvey, P., D.; Davis, K., L., 1998: Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: Prevalence and association with cognitive impairment. Background. Chronically hospitalized geriatric inpatients with schizophrenia are at particular risk for both tardive dyskinesia (TD) and cognitive impairment but have been insufficiently studied in this regard. Similarly, the relationship between...

Holden, T.J., 1987: Tardive dyskinesia in long-term hospitalised Zulu psychiatric patients. A prevalence study. A survey of long-term hospitalised Zulu psychiatric patients at Ekuhlengeni Sanatorium, Umbogintwini, Natal, revealed a 31% incidence of neuroleptic-related abnormal movements. Length of hospitalisation was the only risk factor significantly assoc...

Holden T.J., 1987: Tardive dyskinesia in long term hospitalized zulu psychiatric patients a prevalence study. A survey of long-term hospitalized Zulu psychiatric patients at Ekuhlengeni Sanatorium, Umbogintwini, Natal [South Africa] revealed a 31% incidence of neuroleptic-related abnormal movements. Length of hospitalization was the only risk factor signi...

Müller-Spahn, F.; Ackenheil, M.; Albus, M.; May, G.; Naber, D.; Welter, D.; Zander, K., 1984: Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia. The sensitivity of the dopaminergic hypothalamic pituitary system, as indicated by growth hormone (GH) release after apomorphine (0.5 mg SC), was studied in 11 chronic schizophrenic in-patients under long-term neuroleptic (NL) therapy and after 12...

Cohen, S.; Khan, A.; Zheng, Y.; Chiles, J., 1991: Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population. Thirty mentally retarded patients treated with neuroleptics for aberrant behavior were compared with 30 neuroleptic-treated schizophrenics for the presence, topography and risk factors associated with tardive dyskinesia (TD). In the total sample (...

Go, C.L.; Rosales, R.L.; Caraos, R.J.; Fernandez, H.H., 2010: The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients. To determine the prevalence of and the factors associated with tardive dyskinesia (TD) among Filipino patients with schizophrenia admitted at the National Center for Mental Health. Cross-sectional study. A total of 227 inpatients fulfilling the DS...

Gharabawi, G.M.; Bossie, C.A.; Zhu, Y.; Mao, L.; Lasser, R.A., 2005: An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study. Introduction: Treatment-emergent tardive dyskinesia (TD) can be a serious side effect of antipsychotic treatment. Atypical antipsychotics are associated with a lower risk for TD than are conventional agents. A long-acting atypical antipsychotic, w...

Morgenstern, H.; Glazer, W.M., 1993: Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Objectives: To describe the incidence of tardive dyskinesia (TD) in the Yale TD Study and to identify demographic, treatment, and clinical risk factors for TD occurrence. Design: An ongoing prospective cohort study in which subjects have been exam...